⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 10, 2024Frontiers in ImmunologyOpen Access

Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM

Dongyun Rong Yushen Su Dechao Jia Zhirui Zeng Yan Yang Dalong Wei Honguan Lu Yu Cao

View Full Paper

Ask AI

Bookmark

Share

Abstract

Skin Cutaneous Melanoma (SKCM) incidence is continually increasing, with chemotherapy and immunotherapy being among the most common cancer treatment modalities. This study aims to identify novel biomarkers for chemotherapy and immunotherapy response in SKCM and explore their association with oxidative stress.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rong et al. (2024) studied this question.

synapsesocial.com/papers/68e6f97db6db6435876745d7 https://doi.org/10.3389/fimmu.2024.1387316

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response2025 · 31 citations
2Identification of a Treg-related gene signature for predicting prognosis and immunosuppression in skin cutaneous melanoma2025
3Development and validation of a cuproptosis-immune prognostic signature for risk stratification and personalized therapy in cutaneous melanomaOriginal Research · 2026
4Oxidative stress‐driven metabolic reprogramming defines two subtypes of cutaneous melanomaHuman Clinical Trial · 2026
5Integrated transcriptomic and immunological profiling reveals new diagnostic and prognostic models for cutaneous melanoma2024 · 2 citations